Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?

Withdrawn before enrolling · Phase 4

Conditions studied: Clavicle Fracture

In brief

To determine whether liposomal bupivacaine wound infiltration decreases pain scores and narcotic use when compared to bupivacaine alone after open reduction internal fixation of midshaft clavicle fractures.

Key facts

Study ID

NCT03020563

Run by

University of Minnesota

People needed

0

Starts

2017-08-23

Expected to finish

2018-01-01

Last updated by the study team

2018-10-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mid-shaft Clavicle Fracture treated with ORIF

You may not qualify if…

• Unable to be contacted for 72 hours post surgery
• Other concurrent surgical procedures
• Chronic narcotic user

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.